About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,370 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,370 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4981-5000 of 11,370 trials

CompletedStudy of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of ChemotherapyThis is a phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable Locally Advanced and/or Metastatic Ewing Family…NCT01222767·Santa Monica, California and 6 others CompletedQuality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate CancerRATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate-term and long-term effects of surgery and brachytherapy.NCT00052481·San Francisco, California and 12 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

TerminatedGemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine hydrochloride and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or…NCT01041781·Anniston, Alabama and 399 others

Active not recruitingA Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)This study will evaluate the pharmacokinetics (PK), safety, and tolerability of a new formulation of Cabotegravir (CAB) dosed every 4-months (Q4M) for pre-exposure prophylaxis…NCT06741397·Birmingham, Alabama and 26 others

CompletedEfficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderThe purpose of this study is to determine the safety and efficacy of vortioxetine, once daily (QD), in adults with generalized anxiety disorder.NCT00730691·Anaheim, California and 65 others

CompletedDiabetes Health Enhancement Program to Improve Health of People With DiabetesManagement of chronic diseases, such as diabetes, relies upon the health care providers and the patients self-care.NCT00291590·Seattle, Washington

Active not recruitingA Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseThe purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by assessing reduction in axial…NCT04929210·Avondale, Arizona and 241 others

Active not recruitingPilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ LeukemiaPatients with relapsed or refractory CD 19+ leukemia who have achieved remission after CD19 CAR-T cell treatment sometimes relapse because the CD 19 CAR-T cells decrease in number…NCT03186118·Seattle, Washington

CompletedStudy of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin LymphomaRATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers…NCT00981097·La Jolla, California and 15 others

CompletedStudy to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]This is a Phase III, global, multicenter, open-label, randomized study to compare the efficacy and safety of 16 cycles (1 cycle duration=21 days) of atezolizumab (MPDL3280A)…NCT02486718·Fayetteville, Arkansas and 215 others

CompletedEvaluation of the Efficacy and Safety of LevoCeptTo evaluate the effectiveness, device placement, safety, and tolerability of LevoCept to support commencing a Phase III Clinical StudyNCT02882191·Berkeley, California and 15 others

TerminatedStudy of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue SarcomaThis is an international, randomized, double-blind, placebo-controlled trial to evaluate the clinical efficacy of palifosfamide-tris administered with doxorubicin in combination…NCT01168791·Birmingham, Alabama and 160 others

TerminatedA Study of ASP2074 in Adults With Solid TumorsASP2074 is a potential new treatment for people with certain solid tumors.NCT05646797·Sacramento, California and 12 others

RecruitingTebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)The purpose of this study is to evaluate the efficacy and safety of tebentafusp-based regimens, including tebentafusp monotherapy and in combination with anti-PD1 vs investigator…NCT05549297·Phoenix, Arizona and 81 others

CompletedStudy of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With DocetaxelThis is a Phase II, non-randomized, open label study of ILX651 in patients with hormone-refractory prostate cancer previously treated with docetaxel.NCT00082134·Tucson, Arizona and 11 others

CompletedAn Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid TumorsThe purpose of the study is to assess the safety, tolerability and effectiveness of experimental medication BMS-986016 administered alone and in combination with nivolumab in…NCT01968109·La Jolla, California and 53 others

CompletedMobile Subthreshold Exercise Program for ConcussionNon-randomized pilot intervention using mobile-administered sub-threshold exercise to treat youth with prolonged symptoms of concussion.NCT03691363·Seattle, Washington

CompletedEfficacy and Safety Study of Ozanimod in Relapsing Multiple SclerosisThis study is a two-part trial consisting of Part A (see NCT01628393) and Part B, presented within this record.NCT02047734·Phoenix, Arizona and 298 others

Active not recruitingStudy to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisStudy RNLC3131 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first…NCT05071716·Dothan, Alabama and 149 others

Active not recruitingStudy of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)The main objective of this study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia…NCT06073821·Anchorage, Alaska and 200 others

PreviousPage 250 of 569Next

in Seattle

Heart Diseasein Seattle